Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting...

37
Pathology Post- Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline Subcommittee Advocacy Committee Thanks goes to Priscilla Markwood and Jen Norman for the SurveyMonkey

Transcript of Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting...

Page 1: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Pathology Post-Sophomore Fellowship Survey

American Board of PathologyCooperating Societies Meeting

May 5, 2015Wesley Naritoku, M.D., Ph.D.Chair, Pipeline Subcommittee

Advocacy CommitteeThanks goes to Priscilla Markwood and Jen Norman for the SurveyMonkey

Page 2: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Introduction and Background

• Pathology workforce shortage anticipated• Pipeline Subcommittee of APC Advocacy

Committee formed, July 2014• One of many interests: advanced credit for the

Post-Sophomore Fellowship (PSF) graduates• PSF not a new concept – Whipple 1926• Many studies in the literature point to the fact

that PSF graduates choose pathology more than non-PSF and more go into academics

Page 3: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Post-sophomore Fellowship Survey

• n = 48 programs total responded (33.8%)• n = 20 programs with post-sophomore

fellowships (PSF) (approaching 100% of PSF)• 28 programs without PSF could answer the first 7

questions focused on experience with PSF graduates and were looped out of the survey

• 20 programs with PSF completed Q8 – Q26 to drill down on characteristics of the PSF programs

Page 4: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q1. How many going into pathology?

• Average per medical school class: 2.8 (1.9%)• Range of # of seniors go into Pathology: 1 – 10• Average size of graduating class: 145.2• Range of # of seniors graduating: 29 – 270

Page 5: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Questions 2 – 6 applies to all responders (PSF and non-PSF programs)

• Q2. How many of your PSF-trained residents pursued an academic career?

• 59.8% (n = 15)

Page 6: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Questions 2 – 6 applies to all responders (PSF and non-PSF programs)

Q3. Of your PSF-trained residents, do you know if any have changed specialty during or after residency or left medicine altogether?

Not Changed: 29 (60.4%)

Changed: 4 (8.3%)

Don’t know: 15 (31.25%)

Page 7: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Questions 2 – 6 applies to all responders (PSF and non-PSF programs)

• Q4. If PSF-trained graduates have changed specialty during or after residency or left medicine altogether? (n = 3)

• Left Pathology for another specialty: 2• Left Medicine altogether: 1

Page 8: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Questions 2 – 6 applies to all responders (PSF and non-PSF programs)

• Q5. Type of training PSF did during residency and after:

• AP/CP residency: vast majority• AP only: distant second• CP only: 1• AP/NP: 0• Did fellowship after residency: many

Page 9: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Questions 2 – 6 applies to all responders (PSF and non-PSF programs)

Answered: 31Skipped: 18

Page 10: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q8. Does your medical school have a PSF program?

Yes: 20 (50%) No: 16 (40%)

Page 11: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q9. The PSF Director is:

Page 12: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q10. How many years has your PSF been in existence?

n = 20

Page 13: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q11. How many students have completed the PSF at your institution?• Average: 45.7• Range: 3 – 180• n = 20

Page 14: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q12. Total # of PSF that went into Pathology?

• Average: 21.8• Range: 1 – 105• n = 19

Page 15: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q13. Total # of PSF that went into Pathology, that stayed at same program?

• Average: 9.9• Range: 0 – 20• n = 17

Page 16: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q14. Who is responsible for direct supervision of the PSF?

Page 17: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q15. Is there a point in training where the PSF is on ‘Indirect Supervision’

n = 20

Page 18: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q16. Do you have separate (dedicated) learning G&O’s for PSF?

n = 20

Page 19: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q17. Are the learning G&O’s competency-based and robust?

Page 20: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q19. How do you evaluate the PSF?

n = 20

Page 21: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q20. Please list the number of weeks that a typical PSF has of the following subspecialty areas out of 52 weeks:

Page 22: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q20. Please list the number of weeks that a typical PSF has of the following subspecialty areas out of 52 weeks:

Page 23: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q21. How do you evaluate the quality and efficacy of your PSF program? (check all that applies)

Page 24: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q22. If the PSF performs autopsies, do they share with a resident or solo?

Page 25: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q23. If the PSF performs autopsies, do they participate in all 7 components of the autopsy as defined by ACGME?

No: 1 (5%)

Page 26: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q24. If the PSF grosses Surgical Pathology, do they take ownership over the case as would a PGY1 (sign-outs, synoptic

reporting, cancer staging, histochem, IHC, molecular)

Page 27: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q25. Do you feel that students completing a PSF should receive advanced standing?

Page 28: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

In Favor Of:

• They essentially function as first-year residents

• They are usually miles ahead of the average medical student going into pathology

Page 29: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Neutral, favoring ‘oppose’

• I would have to change my PSF if they were to get advanced credit. We have made it less intense in the past years…Some PSF are a yr long and some are less. Great variability.

Page 30: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Opposed

• I don't unless we go back to five year programs

Page 31: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

If you have a PSF, is it mainly: •A passive observership 5.3% (1)•Essentially it is like PGY1 year 63.2% (12)•Somewhere in between ‘a’ and ‘b’ 26.3% (5)•No answer from 5.3% (1) Comments: 2n = 19

Page 32: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Programs ‘opposed’

• n = 7 programs opposed or neutral• 2 programs run their PSF somewhere between

a passive observership and a PGY1 year• 5 programs run their PSF essentially like a

PGY1 year

Page 33: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Programs ‘In Favor’

• 2 programs that describe their PSF as somewhere in between a passive observership and a PGY1 were in favor of awarding advanced credit.

Page 34: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Q26. Who do you feel should ‘accredit’ the PSF in Pathology?

ACGME: 12 (60%)

LCME: 2 (10%)

Other 6 (30%)

Page 35: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

A former PSF, now APDI spent a year rotating on all AP services including surgical pathology, cytopathology and autopsy pathology. I also did an elective in forensics and one in neuropathology…this year was of indescribably value to my career. I learned more this year than during my 1st year of residency including how to gross all major specimens and all the most common diagnostic encounters in pathology. When I applied for residency I received offers to interview at every single place I wanted to go. During interviews numerous attendings told me how highly they values attaining PSFs as incoming residents because they are more than well prepared. My medical school grades were not AOA level and my Step 1 score of moderate at best, but I matched at the #1 Pathology residency program in the nation…I STRONGLY feel this year should be given the credit it deserves, as from my experience, it is rigorous training at the same or higher level than residency training at most institutions.

Page 36: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Concluding comments from MacPherson (ref 7)

“Although the Board’s decision is understandable in the context of requiring only 4 rather than 5 years of postgraduate training, ignoring the student fellowship experience completely is unreasonable in this era of competency-based residency training. I would propose that the Board continue to require program directors to register their student fellowship programs, submit accurate program descriptions, provide appropriate supervision of the program, preferably by the director of the residency program, and compile data concerning the outcome of graduates from these student fellowship programs. In return, I propose that the student fellows receive partial or limited credit for their experience (eg, credit for their autopsy experience), which would permit them to increase the flexibility (ie, electives) of their 4-year residency program. Naturally, any credit for these activities would be awarded at the discretion of the program director.”

Page 37: Pathology Post-Sophomore Fellowship Survey American Board of Pathology Cooperating Societies Meeting May 5, 2015 Wesley Naritoku, M.D., Ph.D. Chair, Pipeline.

Thank you for the opportunity to present

Wesley Y. Naritoku, MD, PhDImmediate Past Chair, PRODSChair, Pipeline Subcommittee